icon-folder.gif   Conference Reports for NATAP  
 
  IDSA
ID Week 2026
October 21-24
Washington, DC

Back grey_arrow_rt.gif
 
 
 
Week 48 Efficacy and Safety of Doravirine/Islatravir (100 mg/0.25 mg) vs Bictegravir/Emtricitabine/Tenofovir Alafenamide in Previously Untreated Adults Living With HIV-1 With Renal Impairment
 

 
 
  IDSA Oct 21-24 Wash DC
 

1021261copy

1021262copy

1021263copy

1021264copy

1021265copy

1021266copy

1021267copy

1021268copy

1021269copy